Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/181039Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Ingen, Jakko van | - |
| dc.contributor.author | Aliberti, Stefano | - |
| dc.contributor.author | Andrejak, Claire | - |
| dc.contributor.author | Chalmers, James D. | - |
| dc.contributor.author | Codecasa, Luigi R. | - |
| dc.contributor.author | Daley, Charles L. | - |
| dc.contributor.author | Hasegawa, Naoki | - |
| dc.contributor.author | Griffith, David E. | - |
| dc.contributor.author | Hoefsloot, Wouter | - |
| dc.contributor.author | Huitt, Gwen | - |
| dc.contributor.author | Jarand, Julie | - |
| dc.contributor.author | Jhun, Byung Woo | - |
| dc.contributor.author | Loebinger, Michael R. | - |
| dc.contributor.author | Marras, Theodore K. | - |
| dc.contributor.author | Morimoto, Kozo | - |
| dc.contributor.author | Polverino, Eva | - |
| dc.contributor.author | Ringshausen, Felix C. | - |
| dc.contributor.author | Santín Cerezales, Miguel | - |
| dc.contributor.author | Thomson, Rachel | - |
| dc.contributor.author | Wagner, Dirk | - |
| dc.contributor.author | Wallace, Richard J. | - |
| dc.contributor.author | Winthrop, Kevin L. | - |
| dc.contributor.author | Yim, Jae-joon | - |
| dc.date.accessioned | 2021-11-04T13:25:53Z | - |
| dc.date.available | 2021-11-04T13:25:53Z | - |
| dc.date.issued | 2020-09-10 | - |
| dc.identifier.issn | 1537-6591 | - |
| dc.identifier.uri | http://hdl.handle.net/2445/181039 | - |
| dc.description.abstract | Adverse events are frequent in nontuberculous mycobacteria pulmonary disease treatment, but evidence to support their management is scarce. An expert panel survey on management of adverse events shows consistent opinions on management of hepatoxicity, ocular toxicity, ototoxicity, tinnitus, and gastrointestinal upset. These opinions can provide assistance in individual patient management decisions. | - |
| dc.format.extent | 4 p. | - |
| dc.format.mimetype | application/pdf | - |
| dc.language.iso | eng | - |
| dc.publisher | Oxford University Press (OUP) | - |
| dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1093/cid/ciaa1361 | - |
| dc.relation.ispartof | Clinical Infectious Diseases, 2020 | - |
| dc.relation.uri | https://doi.org/10.1093/cid/ciaa1361 | - |
| dc.rights | cc by-nc-nd (c) Ingen, Jakko van et al, 2020 | - |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/es/ | * |
| dc.source | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) | - |
| dc.subject.classification | Malalties del pulmó | - |
| dc.subject.classification | Antibiòtics | - |
| dc.subject.other | Pulmonary diseases | - |
| dc.subject.other | Antibiotics | - |
| dc.title | Management of Drug Toxicity in Mycobacterium avium Complex Pulmonary Disease: An Expert Panel Survey | - |
| dc.type | info:eu-repo/semantics/article | - |
| dc.type | info:eu-repo/semantics/publishedVersion | - |
| dc.date.updated | 2021-11-04T12:15:58Z | - |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
| dc.identifier.pmid | 32910814 | - |
| Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| ciaa1361.pdf | 166.86 kB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License
